MARKET NEWS

English
Specials
Moneycontrol Be a PRO
you are here:
Success
Alert
Please select a Day.
Info
Open Trading Account

Ajanta Pharma Ltd.

Sector: Pharmaceuticals
Add to
2,005.00
62.05 (3.19%)

As on 12 May, 2021 | 04:00

Trade
Day Range
1890.00
2009.90
L H
52 Week Range
1331.00
2049.00
L H
Volume
188,951
*
i

* BSE Market Depth (12 May 2021)

BUY SELL
QTY PRICE PRICE QTY
50 1997.00 2010.70 4
3 1991.00 2012.00 1
1 1981.00 2014.70 2
10 1971.00 2015.00 53
5 1970.00 2018.25 8
1149 Total Total 879
Bid / Ask
1991.00 / 2002.95
Advance Chart
2,002.95
60.45 (3.11%)

As on 12 May, 2021 | 04:00

Day Range
1930.00
2010.70
L H
52 Week Range
1330.00
2047.85
L H
Volume
6,076
*
i

* BSE Market Depth (12 May 2021)

BUY SELL
QTY PRICE PRICE QTY
50 1997.00 2010.70 4
3 1991.00 2012.00 1
1 1981.00 2014.70 2
10 1971.00 2015.00 53
5 1970.00 2018.25 8
1149 Total Total 879
Bid / Ask
1991.00 / 2002.95
Advance Chart
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
MC Essentials
81% Pass
MC Technicals
 Trend
i
This represents current trend.Click here for disclaimer.
MC Insights

Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

Financials
    Ownerships
      Industry Comparison
        Others
          Powered by Powered by Trendlyne
          Open1,962.00
          Previous Close1,942.95
          UC Limit2,331.50
          LC Limit1,554.40
          Volume188,951.00
          VWAP1,986.09
          Mkt Cap (Rs. Cr.)17,350
          20D Avg Volume238,752
          20D Avg Delivery91,830
          Beta0.300.27
          Face Value2.00
          TTM EPS75.56
          TTM PE26.54
          Sector PE42.44
          Book Value Per Share375.82
          P/B5.34
          Dividend Yield0.65
          P/C22.53

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 50.75% away from 52 week low
          • 2.15% away from 52 week high
          • Outperformer - Ajanta Pharma up by 17.33% v/s NIFTY 50 up by 2.7% in last 1 month
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          6

          indicates Average Financials

          3 year CAGR growth
          Revenue 10.7%
          NetProfit 11.7%
          OperatingProfit 14.9%
          Industry Comparison
          • TTM PE Ratio - Above industry Median
          • Market Cap - High in industry
          • Price to Book Ratio - Above industry Median
          • TTM PEG Ratio - Above industry Median
          Shareholding Pattern
          • Promoters pledged 0.32% of shares in last quarter. Total pledge stands at 15.49% of promoter holdings
          • Promoters holding remains unchanged at 70.34% in Mar 2021 qtr
          • Mutual Funds have decreased holdings from 9.78% to 9.53% in Mar 2021 qtr
          • Number of MF schemes decreased from 16 to 15 in Mar 2021 qtr
          • FII/FPI have increased holdings from 7.9% to 8.37% in Mar 2021 qtr.
          • Number of FII/FPI investors decreased from 184 to 176 in Mar 2021 qtr
          • Institutional Investors have increased holdings from 20.37% to 20.99% in Mar 2021 qtr.
          Powered by Powered by Trendlyne

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis

          News

          Hot Stocks: BHEL, BEL & Ajanta Pharma top stocks to buy for short term

          Hot Stocks: BHEL, BEL & Ajanta Pharma top stocks to buy for short term

          May 07 2021 07:05 AM

          ₹ Earning + See More

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Ajanta Pharma

          What's your call on Ajanta Pharma today?

          Read 22 investor views

          BUY SELL HOLD
          POST

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          18 Apr, 2019

          KOTAK MAHINDRA (INTERNATIONAL) LTD

          Qty 505977 Price 1033 % Traded 0.58
          17 Jan, 2013

          RBA FINANCE AND INVEST CO

          Qty 350000 Price 399.44 % Traded 0.40
          17 Jan, 2013

          RBA FINANCE AND INVEST CO

          Qty 150000 Price 397.5 % Traded 0.17
          17 Jan, 2013

          RAMJIDAS & SONS

          Qty 350000 Price 399.44 % Traded 0.40
          17 Jan, 2013

          RAMJIDAS & SONS

          Qty 150000 Price 397.5 % Traded 0.17
          16 May, 2011

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 66758 Price 278.92 % Traded 0.08
          16 May, 2011

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 66758 Price 279.75 % Traded 0.08
          11 Apr, 2011

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 114454 Price 232.14 % Traded 0.13

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          + Show More
          Powered by Powered by Trendlyne

          Insider Transaction Summary

          May, 10, 2021

          SAM SOTIRIOS GIOSKOS

          Designated Person
          Qty 3750 Price 1964.66 % Traded 0.00 Post Tnx Hold. 0%
          Mar, 24, 2021

          Aayush M Agrawal, trustee Aayush Agrawal Trust

          Promoter
          Qty 670000 Price 1778.8 % Traded 0.77 Post Tnx Hold. 14.36%
          Mar, 12, 2021

          Aayush M Agrawal, trustee Aayush Agrawal Trust

          Promoter
          Qty 35000 Price 1800.05 % Traded 0.04 Post Tnx Hold. 14.36%
          Feb, 12, 2021

          Shailesh Singh

          Designated Person
          Qty 2500 Price 1811.78 % Traded 0.00 Post Tnx Hold. 0.02%
          Feb, 12, 2021

          Aayush M Agrawal, trustee Aayush Agrawal Trust

          Promoter
          Qty 115000 Price 1816.6 % Traded 0.13 Post Tnx Hold. 14.36%
          Feb, 09, 2021

          Shailesh Singh

          Designated Person
          Qty 7500 Price 1805.68 % Traded 0.01 Post Tnx Hold. 0.02%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Show All Transactions
          Jul, 11, 2017

          Ganga Exports,a Partnership Firm

          Promoter
          Qty 2700000 Price 0 % Traded 3.07 Post Tnx Hold. 0.37%
          Nov, 21, 2016

          Yogesh M Agrawal & Rajesh M Agrawal

          Other
          Qty 2703360 Price 0 % Traded 3.08 Post Tnx Hold. 0%
          Nov, 21, 2016

          Yogesh M Agrawal & Rajesh M Agrawal

          Promoter
          Qty 2703360 Price 0 % Traded 1.53 Post Tnx Hold. 3.07%
          Nov, 21, 2016

          Yogesh M Agrawal & Rajesh M Agrawal

          Promoter
          Qty 2703360 Price 0 % Traded 3.07 Post Tnx Hold. 3.07%
          Nov, 10, 2016

          Yogesh M Agrawal

          Promoter
          Qty 2703360 Price 0 % Traded 3.08 Post Tnx Hold. 0%
          Sep, 26, 2016

          Yogesh M Agrawal

          Other
          Qty 30839779 Price 0 % Traded 35.06 Post Tnx Hold. 0%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Show All Transactions

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend
          Insights
          Institutional Holder Analysis Total Number Change Total Holding (%) Change
          MF Schemes (Mar 2021) 15 -1 9.53 -0.25
          FII/FPI (Mar 2021) 126 -7 8.37 0.47

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          Ajanta Pharma 2005.00 3.19 17349.62 26.54 5.34 21.82 39.17 653 2,889 0.00
          Sun Pharma 702.85 -0.74 168637.26 65.81 3.43 8.31 51.51 4,186 32,837 0.17
          Divis Labs 4061.45 -0.30 107818.74 57.64 14.75 18.83 71.84 1,376 5,394 0.00
          Dr Reddys Labs 5301.45 0.10 88163.77 40.53 5.65 12.98 40.50 1,969 17,517 0.11
          Cipla 898.60 0.86 72468.79 32.39 4.53 9.81 57.61 1,546 17,131 0.18
          + See More

          About the Company

          Ajanta Pharma Limited (APL), is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales. They cater to therapeutic areas like cardiology, ophthalmology and dermatology.They manufacture various dosage forms such as tablets, capsules, injections, ointments and powders. The companys research and development division conduct activities in three aspects namely new drug delivery system (NDDS), formulation and development and herbal/ nutraceutical.
          {"success":1,"data":{"address":{"address1":"\"Ajanta House\",","address2":"Charkop,,Kandivli (West),","city":"Mumbai","state":"Maharashtra","pincode":"400067","telephone1":"022-66061000","telephone2":"","fax1":"022-66061200","fax2":"022-66061300","email":"info@ajantapharma.com","web":"http:\/\/www.ajantapharma.com"},"management":[{"name":"Mannalal B Agrawal","designation":"Chairman"},{"name":"Madhusudan B Agrawal","designation":"Vice Chairman"},{"name":"Yogesh M Agrawal","designation":"Managing Director"},{"name":"Rajesh M Agrawal","designation":"Joint Managing Director"},{"name":"Chandrakant M Khetan","designation":"Independent Director"}],"registrars":{"name":"Link Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West)","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"532331","nseId":"AJANTPHARM","series":"EQ","isinid":"INE031B01049"}}}

          • Registered Office

          • Registrars

          • Management

            • Mannalal B Agrawal

              Chairman

            • Madhusudan B Agrawal

              Vice Chairman

            • Yogesh M Agrawal

              Managing Director

            • Rajesh M Agrawal

              Joint Managing Director

            • Chandrakant M Khetan

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

          • Details

            • BSE:

              532331

            • NSE:

              AJANTPHARM

            • Series

              EQ

            • ISIN

              INE031B01049

          Go to Top

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>

          Sections
          Desktop Version »
          Follow us on
          Facebook Twitter Instagram Teglegram Jio News
          Available On
          Download from Google Play Download from App Stoer Download from Windows Phone
          Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Contact Us | Advertise with Us
          Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

          Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.